Roivant Sciences Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 121,906 shares at $12.90 ($1.6M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market purchase of $1.6M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |